Reward processing dysfunction in ventral striatum and orbitofrontal cortex in Parkinson's disease

Parkinsonism Relat Disord. 2018 Mar:48:82-88. doi: 10.1016/j.parkreldis.2017.12.024. Epub 2017 Dec 24.

Abstract

Background: Parkinson's disease is a growing concern as the longevity of the world's population steadily increases. Both ageing and Parkinson's disease have an impact on dopamine neurotransmission. It is therefore important to investigate their relative impact on the fronto-striatal reward system. There has been little investigation of reward processing in terms of anticipation and reward outcome in Parkinson's disease. Abnormal responses during reward processing have previously been demonstrated in whole-brain analysis of Parkinson's patients with mild lateralized disease, but the exact impact in regions specific to reward processing is still unknown.

Objective: Here we aim to investigate the impact of Parkinson's disease on the orbitofrontal ventral striatal reward system in patients with moderate to severe clinical symptoms.

Methods: We utilized a monetary incentive delay (MID) task in 17 Parkinson's patients who were compared to two control groups stratified by age. The MID paradigm reliably activates the ventral striatum during reward anticipation and the orbitofrontal cortex during reward outcome processing.

Results: Relative to the two control groups, Parkinson's disease patients had abnormal task related activity during both reward anticipation in the ventral striatum and reward outcome in the orbitofrontal cortex. There were no effects of ageing.

Conclusion: These findings demonstrate abnormalities in anticipatory as well as reward outcome processing while treated primarily with levodopa. The orbitofrontal dysfunction during reward outcome processing may have specificity in Parkinson's disease, as it has been shown to be relatively unaffected by normal ageing.

Keywords: Orbitofrontal cortex; Parkinson's disease; Reward processing; Ventral striatum.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antiparkinson Agents / therapeutic use
  • Female
  • Humans
  • Image Processing, Computer-Assisted
  • Levodopa / therapeutic use
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Motivation
  • Oxygen / blood
  • Parkinson Disease / diagnostic imaging
  • Parkinson Disease / drug therapy
  • Parkinson Disease / pathology*
  • Prefrontal Cortex / diagnostic imaging
  • Prefrontal Cortex / physiopathology*
  • Reaction Time
  • Reward*
  • Ventral Striatum / diagnostic imaging
  • Ventral Striatum / physiopathology*

Substances

  • Antiparkinson Agents
  • Levodopa
  • Oxygen